The Chicago School of Professional Psychology (The Chicago School) is a private university with its main campus in Chicago, Illinois. It has more than 5,700 students at campuses across the United States. The university offers more than 30 academic programs in a variety of professional fields such as psychology, business, health care, health services, education, counseling, and nursing.
Control beliefs are central to depressive symptomatology, yet research has primarily examined perceived and desired control either in isolation or without consideration of how individuals perceive their degree of alignment. The present study tested a triadic calibration framework, proposing that depression risk is shaped not only by perceived and desired control, but also by their metacognitive alignment, termed control discrepancy. A community sample of 942 adults (Mage = 36.7, SD = 17.6; 56.9
This article provides an executive summary of the American Psychological Association's revised Practice Guidelines Regarding Psychologists' Involvement in Pharmacological Issues. The revision was requested by the American Psychological Association Society for Prescribing Psychology (Division 55) and was approved by the American Psychological Association Council of Representatives in August 2025. The task force updated and expanded the guidelines' empirical, theoretical, and practical bases, which reflect the substantial growth in psychologists' roles in pharmacotherapy, including expanded prescriptive authority and collaboration with medical providers. The revision integrates new research, ethical standards, and practical considerations to support safe, evidence-based, and patient-centered pharmacological practice. In this executive summary, we include key points from each of the 14 guidelines. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
Subjective cognitive decline (SCD) refers to cognitive concerns that may occur with or without objective impairment on standardized testing. Studies suggest that SCD may be an early clinical marker of Alzheimer's disease and related dementias, and that it can predict future objective cognitive decline and progression to dementia. However, the research that supports these conclusions is primarily based on samples with homogeneous socioeconomic and cultural backgrounds. The limited studies in samples with more diverse representations of racial, ethnic, gender, and sexual orientation characteristics show varying SCD prevalence, correlates, and outcomes. Here, we review this literature, focusing on how to apply the findings to advance our understanding of SCD. We further evaluate how our findings inform a roadmap for future research. Overall, we conclude that broader investigations across more diverse populations enhance our understanding of the factors that may differentially contribute to SCD and shape its utility as a clinical metric.
